May 23, 2019

Transplant of Neural Stem Cells into ALS Patients Safe, Phase 1 Trial Shows

Posted by in categories: biotech/medical, neuroscience

Injection of human neural stem cells into the spinal cord of people with amyotrophic lateral sclerosis (ALS) was found safe and did not cause adverse effects even two years after the transplant, results from a Phase 1 clinical trial show.

Trial findings were published in the study, “Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome,” in the journal Stem Cells Translational Medicine.

Read more

Comments are closed.